Akso Health Group (AHG) Fundamentals 2026 — Revenue Analysis | SniperIQ
Akso Health Group (AHG) is a CN-listed Technology company in Software - Services with a market capitalization of
Full research coverage
- 8-Quarter Revenue & Margin Trend
- Debt Maturity & Coverage
- Peer Valuation Comparison
- Free Cash Flow & Owner Earnings
- AI Signal + Institutional Flow
- DCF Valuation Model
Frequently Asked Questions
What is Akso Health Group's market cap?
Akso Health Group (AHG) has a market capitalization of approximately
What is Akso Health Group's P/E ratio?
Akso Health Group's trailing twelve-month P/E ratio is not meaningful (negative or nil earnings), with a price-to-book (P/B) of 1.1x. Valuation multiples are best compared with Technology sector peers rather than read in isolation.
How profitable is Akso Health Group?
Akso Health Group runs a net profit margin of -914.1%, a gross margin of 1.0%, and an operating margin of -1126.5%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.
How much revenue does Akso Health Group generate?
Akso Health Group reported revenue of
Does Akso Health Group pay a dividend?
Akso Health Group does not currently show a material trailing dividend yield; it is positioned more as a total-return name. Always confirm the latest dividend policy in the company's filings.
Is Akso Health Group financially healthy?
Akso Health Group carries a debt-to-equity ratio of 0.00x and a current ratio of 1.53x, with a market beta of -1.00. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.
Is Akso Health Group a good stock to buy in 2026?
SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For Akso Health Group (AHG) the key facts are: market cap
Track Akso Health Group's full fundamentals live
Get Akso Health Group's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.